EPCAM and renal cell carcinoma: However, it is deemed inappropriate for use in RCC due to the lack of epithelial cell adhesion molecule (EpCAM) and cytokeratin (CK) expression in CTCs that have undergone epithelial-mesenchymal transition (EMT), a very common phenomenon in this type of tumor [15].